Risk-associated management disparities in acute myocardial infarction

Figure 1. Study flowchart.

Figure 2. Cumulative incidence of 1-year all-cause mortality across patient cohorts with low, intermediate and high risk.

Figure 3. Temporal changes in coronary interventions. (A) Early reperfusion in STEMI; (B) coronary angiography ≤ 3 days in NSTEMI; (C) in-hospital PCI/CABG. Percentages refer to changes in the rates of coronary interventions from 2005/2006 to 2016/2017. p int. refers to the interaction between year of admission and risk group on the utilization of coronary interventions. Odds ratios (OR; with 95% confidence intervals) describe the adjusted associations of the year of admission (2005/2006 vs. 2016/2017) with coronary interventions. STEMI ST-elevation myocardial infarction, NSTEMI non-ST-elevation myocardial infarction, PCI percutaneous coronary intervention, CABG coronary artery bypass grafting.

Figure 4. Temporal changes in pharmacological treatments at discharge. (A) P2Y12-blockers; (B) RAAS-inhibitors. Percentages refer to changes in the rates of pharmacological treatments from 2005/2006 to 2016/2017. p int. refers to the interaction between year of admission and risk group on the utilization of pharmacological treatments. Odds ratios (OR; with 95% confidence intervals) describe the adjusted associations of the year of admission (2005/2006 vs. 2016/2017) with pharmacological treatments. Only in-hospital survivors had been considered. RAAS renin–angiotensin–aldosterone-system.

Figure 5. Temporal changes in follow-up and secondary preventive measures. (A) participation in the 6–10 week follow-up; (B) self-reported smoking cessation; (C) participation in exercise training. Percentages refer to changes in the rates of follow-up participation and achievement of secondary preventive measures from 2005/2006 to 2016/2017. p int. refers to the interaction between year of admission and risk group on the utilization of coronary interventions. Odds ratios (OR; with 95% confidence intervals) describe the adjusted associations of the year of admission (2005/2006 vs. 2016/2017) with coronary interventions. Only patients eligible for the 6–10 week follow-up had been considered.